← Open Payments lookup

DIANA SHENK: Open Payments

NPI 1780380741 · BEL AIR, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,236 in 98 payments from 19 companies in 2025. Trend: 2023 $1,260 · 2024 $2,505 · 2025 $2,236

Food & beverage: $2,156Education: $80
CompanyPaymentsAmount
GlaxoSmithKline, LLC.22$461
Regeneron Healthcare Solutions, Inc.8$273
AstraZeneca Pharmaceuticals LP14$271
Verona Pharma, Inc.14$186
JAZZ PHARMACEUTICALS INC.5$165
Insmed, Inc.5$113
Takeda Pharmaceuticals U.S.A., Inc.3$112
Grifols USA, LLC4$108
Axsome Therapeutics, Inc.3$95
Vifor Pharma, Inc.4$84

Products named: DUPIXENT, NUCALA, Ohtuvayre, XYWAV, TEZSPIRE, TRELEGY ELLIPTA, AREXVY, FASENRA.

Industry payments across MD — which companies pay providers there.